Posaconazole Tablet, Delayed Release
Product Images NDC 73141-023

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 73141-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-100mg (Container 100mg)

This text provides information about Posaconazole Delayed-Release Tablets containing 100 mg of Posaconazole per tablet. The usual dosage is specified in the package insert. It is recommended to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It notes that the Noxafi® Oral Suspension and Delayed-Release Tablets are not interchangeable due to differences in dosing. The tablets are distributed by A2A Integrated Pharmaceuticals with an address in Bowing Green, KY.*

FDA Label Image

Structure (Structure.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.